article thumbnail

Cosette acquires worldwide rights to Endoceutics’ Intraros prescription drug

Pharma Leaders

Cosette Pharmaceuticals has acquired the worldwide rights to prescription drug, Intraros, from Endorecherche’s subsidiary Endoceutics. It is expected to be launched in Asian market in 2025. Intrarosa is said to be the only prescription drug that provides estrogen as well as androgen to treat moderate-to-severe dyspareunia.

article thumbnail

Highlights from The Data Ecosystem in 2025

Prognos Health

Datavant , the leader in helping healthcare organizations securely connect their data and a Prognos Health partner, recently held its Future of Health Data Summit in Washington DC. Summit is a wonderful opportunity for them to share their learnings with the broader healthcare ecosystem.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The continued shame of pharma

World of DTC Marketing

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Nearly 9 in 10 older adults take prescription medication. Still, the pharma industry is fighting hard to keep it off the table.

Pharma 256
article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52
article thumbnail

Are new weight loss drugs an answer or problem?

World of DTC Marketing

A Harvard study found that almost half of Americans are expected to be obese by 2030, accounting for up to 18 percent of healthcare spending on related conditions, ranging from heart disease and stroke to osteoarthritis. . Novo Nordisk more than doubled its sales targets for obesity drugs to $3.7bn by 2025.

article thumbnail

The Inflation Reduction Act Passed, Now What?

PM360

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. healthcare system with major implications for the Medicare Advantage and Medicare Part D programs. On August 16, 2022, President Biden signed the Inflation Reduction Act (IRA) into law.

article thumbnail

Inside the European mass shift to data-driven health solutions

Pharmaceutical Technology

Israel, another leading adopter, has a thriving EHR technology industry that is adapting to the country’s widespread use of Big Data from its country’s healthcare systems. In some countries, EHR is deeply integrated into the entire healthcare system. Adoption of EHR data systems.